IASLC Current webinars

on-demand webinar: novel agents and biomarker-driven therapies for personalized treatment of advanced nsclc

  

 

 

 

 

 

 

 

Novel Agents and Biomarker-driven Therapies for Personlized Treatment of Advanced NSCLC

Implications of the new IASLC staging system and adenocarcinoma classification for systemic treatment of NSCLC - Eric Lim, MB, ChB, MD, MSc, FRCS (C-Th)

Molecular profiling and personalized medicine for patients with lung cancer - David Gandara, MD

The relevance of histological diagnosis in making treatment decisions - Giorgio Scagliotti, MD

Making NSCLC a chronic disease: reality or dream? - Tony Mok, MD

New targets for lung cancer - Suresh Ramalingam, MD

 

on-demand webinar: understanding immunotherapeutic approaches in nsclc

 

 

 

 

 

 

 

 

 

 

Understanding Immunotherapeutic Approaches in NSCLC

 

Basic Concepts in Immunology - Dmitry Gabrilovich, MD, PhD

Immunomodulators for NSCLC - David Carbone, MD, PhD

Vaccines for NSCLC - Johan Vansteenkiste, MD, PhD

 

advanced radiation technology committee announces A LIVE WEBINAR SERIES

Four 60 minute sessions featuring international experts and live Q&A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Session 1:  IGRT/SBRT - Presented by Billy Loo, MD and Suresh Senan, MD 

Session 1:  IGRT/SBRT Introduction - Q&A Session with Dr. Loo and Dr. Senan 

 

If you have trouble hearing the audio, please right-click on the speaker icon on your computer, then select play back devices. Right-click on the device you would like to use to listen to the webinar.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Session 2: Motion Control - Presented by Jan Jakob Sonke, MD and Brian Kavanagh, MD 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Session 3: Treatment Planning - Presented by Robert Timmerman, MD and Timothy Solberg, MD 

 

Session 4: SBRT Delivery - Presented by David Jaffray, MD and Jeffrey Bradley, MD - May 22

Register Now

 

 

THE IASLC SATELLITE SYMPOSIUM IS AVAILABLE ON-DEMAND

2012 Chicago Multidisciplinary Symopsium in Thoracic Oncology

Molecular Testing for Non-Small Cell Lung Cancer: Critical Questions

 

Participate in this multidisciplinary program that reviews key questions in the clinical application of molecular

diagnostics in advanced NSCLC: who, why, what, how, and when to do molecular testing in NSCLC patients.

 

 

Introduction and 10 Most Important Questions.

David Gandara, MD

 

How to Obtain Tissue and Which Tissue to Obtain, How to Coordinate with Pathology.

Harvey I. Pass, MD

 

Treatment Decisions Based on Molecular Findings.

Gregory Riely, MD, PhD

 

Molecular Pathology: Processing Specimens and Minimum Requirements, Tests for ALK and EGFR, Reporting and Timing of the Results.

Ming S. Tsao, MD, FRCPC

 

Question and Answers: Audience Response and Concluding Comments.

David Gandara, MD

 

PLUS BONUS EDUCATIONAL MODULE

 

EGFR and ALK TKI Therapy in Advanced NSCLC: Molecular Basis and When and Why to Stop or Change

Paul A. Bunn, Jr, MD

 

 

Introducing The New IASLC/ATS/ERS Lung Adenocarcinoma Classification

 

In 2011, the Journal for Thoracic Oncology published the “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma,” issued by a multidisciplinary team of lung cancer specialists. To better understand the general implications of this new classification, and the issues affecting specific specialties, please join us for this On-Demand Webinar Series.

Module 1 - Introducing The New IASLC/ATS/ERS Lung Adenocarcinoma Classification  Module 2 - Implications of the New IASLC/ATS/ERS Classification   Module 3 - Highlights for the Pathologist   Module 4 - Highlights for the Radiologist   Module 5 - Case Studies for the Practicing Clinician

 

 

WEBCOURSE

 

 

 

Consideration for Practice: Women and Lung Cancer will feature an introduction by Dr. Joan Schiller, who will discuss the incidence, epidemiology and etiology of lung cancer in women. The introduction is followed by a detailed case presentation by Dr. Edward Garon and Dr. Heather Wakelee regarding disease management, factors for consideration in treatment and decision points as supported by current evidence.

 

 

 

 IASLC webinars

 

	WEBCASTS FROM THE 14TH WORLD CONFERENCE ON LUNG CANCER, JULY 2011   VIRTUAL MEETING   HIGHLIGHTS OF THE WCLC (Oncologie TV)   EGFR MUTATION AND ALK TESTING METHODS IN DIAGNOSTIC PATHOLOGY: Hands-on session, July 3 (VUmc)
	NEW DEVELOPMENTS IN NON-SMALL CELL LUNG CANCER The New Lung Cancer Staging System & Genetic Testing for Optimal Therapy of NSCLC   Please note: CME is no longer available for this activity. The webinar content is available for information purposes.

archives
	2ND EUROPEAN LUNG CANCER CONFERENCE, 2010

CHICAGO MULTIDISCIPLINARY SYMPOSIUM IN THORACIC ONCOLOGY, 2008

 

	1ST EUROPEAN LUNG CANCER CONFERENCE, 2008